CRL
Charles River Laboratories · Health Care
6.3%
typical move (median |reaction| of last 8)
2026-11-04 pre · likely
next expected · estimated from pattern
13
scored events
Last eight reactions
2025-02-19 → 2026-08-05
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-08-05 | pre | +11.4% | 11.4% | +8.8% | +12.5% |
| 2026-05-07 | pre | +0.2% | 0.2% | -14.9% | -1.1% |
| 2026-02-18 | pre | -0.1% | 0.1% | +5.3% | +3.0% |
| 2026-01-13 | pre | -0.1% | 0.1% | +4.8% | -23.9% |
| 2025-11-05 | pre | -5.6% | 5.6% | +1.3% | +8.5% |
| 2025-08-06 | pre | -10.1% | 10.1% | +1.2% | +5.5% |
| 2025-05-07 | pre | +18.8% | 18.8% | -3.3% | -2.6% |
| 2025-02-19 | pre | +6.9% | 6.9% | +4.9% | +12.9% |
Source filings
2026-08-05 · 8-K press release
Charles River Laboratories Announces Second-Quarter 2026 Results WILMINGTON, MA, August 5, 2026 – Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second q
2026-05-07 · 8-K press release
CHARLES RIVER LABORATORIES ANNOUNCES FIRST-QUARTER 2026 RESULTS – Reports First-Quarter Revenue of $995.8 Million, GAAP Loss per Share of $(0.30), and Non-GAAP Earnings per Share of $2.06 – – Reaffirm
2026-02-18 · 8-K press release
CHARLES RIVER LABORATORIES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2025 RESULTS AND PROVIDES 2026 GUIDANCE – Fourth-Quarter Revenue of $994.2 Million and Full-Year Revenue of $4.02 Billion – – Fourth-Q
2026-01-13 · 8-K press release
0001100682 false 0001100682 2026-01-13 2026-01-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exch
2025-11-05 · 8-K press release
CHARLES RIVER LABORATORIES ANNOUNCES THIRD-QUARTER 2025 RESULTS – Third-Quarter Revenue of $1.00 Billion – – Third-Quarter GAAP Earnings per Share of $1.10 and Non-GAAP Earnings per Share of $2.43 – –
2025-08-06 · 8-K press release
CHARLES RIVER LABORATORIES ANNOUNCES SECOND-QUARTER 2025 RESULTS – Second-Quarter Revenue of $1.03 Billion – – Second-Quarter GAAP Earnings per Share of $1.06 and Non-GAAP Earnings per Share of $3.12
2025-05-07 · 8-K press release
CHARLES RIVER LABORATORIES ANNOUNCES FIRST-QUARTER 2025 RESULTS – First-Quarter Revenue of $984.2 Million – – First-Quarter GAAP Earnings per Share of $0.50 and Non-GAAP Earnings per Share of $2.34 –
2025-02-19 · 8-K press release
CHARLES RIVER LABORATORIES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2024 RESULTS AND PROVIDES 2025 GUIDANCE – Fourth-Quarter Revenue of $1.00 Billion and Full-Year Revenue of $4.05 Billion – – Fourth-Qu